European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods by Weiser, P et al.
European network for promoting the physical health of residents in
psychiatric and social care facilities (HELPS): background, aims and
methods
Weiser, P; Becker, T; Losert, C; Alptekin, K; Berti, L; Burti, L; Burton, A; Dernovsek, M;
Dragomirecka, E; Freidl, M; Friedrich, F; Genova, A; Germanavicius, A; Halis, U; Henderson,
J; Hjorth, P; Lai, T; Larsen, JI; Lech, K; Lucas, R; Marginean, R; McDaid, D; Mladenova, M;
Munk-Jorgensen, P; Paziuc, A; Paziuc, P; Priebe, S; Prot-Klinger, K; Wancata, J; Kilian, R
 
 
 
 
 
 
 
For additional information about this publication click this link.
https://qmro.qmul.ac.uk/jspui/handle/123456789/641
 
 
 
Information about this research object was correct at the time of download; we occasionally
make corrections to records, please therefore check the published record when citing. For
more information contact scholarlycommunications@qmul.ac.uk
BioMed Central
Page 1 of 9
(page number not for citation purposes)
BMC Public Health
Open AccessStudy protocol
European network for promoting the physical health of residents in 
psychiatric and social care facilities (HELPS): background, aims and 
methods
Prisca Weiser*1, Thomas Becker1, Carolin Losert1, Köksal Alptekin2, 
Loretta Berti3, Lorenzo Burti3, Alexandra Burton4, Mojca Dernovsek5, 
Eva Dragomirecka6, Marion Freidl7, Fabian Friedrich7, Aneta Genova8, 
Arunas Germanavicius9, Ulas¸ Halis2, John Henderson10, Peter Hjorth11, 
Taavi Lai12, Jens Ivar Larsen11, Katarzyna Lech13, Ramona Lucas14, 
Roxana Marginean15, David McDaid16, Maya Mladenova8, Povl Munk-
Jørgensen11, Alexandru Paziuc15, Petronela Paziuc15, Stefan Priebe4, 
Katarzyna Prot-Klinger13, Johannes Wancata7 and Reinhold Kilian1
Address: 1Department of Psychiatry and Psychotherapy II, Ulm University, Günzburg, Germany, 2Dokuz Eylül Üniversitesi Tip Fakültesi Psykiyatri 
Anabilim Dali, Izmir, Turkey, 3Department of Medicine and Public Health, Universitá degli Studi di Verona, Verona, Italy, 4Queen Mary & 
Westfield College, London, UK, 5Ozara Slovenia Life Quality National Association, Maribor, Slovenia, 6Psychiatrické centrum Praha/Prague 
Psychiatric Centre, Praha/Prague, Czech Republic, 7Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria, 
8Fondatzia za Choveshki Otnoshenia, Sofia, Bulgaria, 9Vilnius University, Vilnius, Lithuania, 10Mental Health Europe-Sante Mentale Europe, 
Brussels, Belgium, 11Unit for Psychiatric Research, Åalborg Psychiatric Hospital, Aarhus University, Åalborg, Denmark, 12Department of Public 
Health, University of Tartu, Tartu, Estonia, 13Institute of Psychiatry and Neurology, Warsaw, Poland, 14Fundació Institut Català de l'Envelliment, 
Universitat Autonoma de Barcelona, Barcelona, Spain, 15Campulung Moldovenesc Psychiatric Hospital, Campulung Moldovenesc, Romania and 
16London School of Economics and Political Science, London, UK
Email: Prisca Weiser* - prisca.weiser@uni-ulm.de; Thomas Becker - t.becker@uni-ulm.de; Carolin Losert - carolin.losert@bkh-guenzburg.de; 
Köksal Alptekin - koksal.alptekin@deu.edu.tr; Loretta Berti - loretta.berti@univr.it; Lorenzo Burti - lorenzo.burti@univr.it; 
Alexandra Burton - a.burton@qmul.ac.uk; Mojca Dernovsek - mojca-zvezdana.dernovsek@guest.arnes.si; 
Eva Dragomirecka - dragomirecka@pcp.lf3.cuni.cz; Marion Freidl - marion.freidl@meduniwien.ac.at; 
Fabian Friedrich - fabian.friedrich@meduniwien.ac.at; Aneta Genova - aneta@bghelsinki.org; 
Arunas Germanavicius - arunas.germanavicius@vrc.vu.lt; Ulas¸ Halis - halisulas@yahoo.com; John Henderson - mac53@talktalk.net; 
Peter Hjorth - peter.hjorth@rn.dk; Taavi Lai - taavi.lai@ut.ee; Jens Ivar Larsen - jil@rn.dk; Katarzyna Lech - gabinet@harmony.pl; 
Ramona Lucas - Ramona.Lucas@uab.cat; Roxana Marginean - marginean_roxana@yahoo.com; David McDaid - D.Mcdaid@lse.ac.uk; 
Maya Mladenova - mmladenova@datacom.bg; Povl Munk-Jørgensen - pmj@rn.dk; Alexandru Paziuc - apaziuc@yahoo.com; 
Petronela Paziuc - elapaziuc@yahoo.com; Stefan Priebe - s.priebe@qmul.ac.uk; Katarzyna Prot-Klinger - k.prot@wp.pl; 
Johannes Wancata - johannes.wancata@meduniwien.ac.at; Reinhold Kilian - reinhold.kilian@uni-ulm.de
* Corresponding author    
Abstract
Background: People with mental disorders have a higher prevalence of physical illnesses and
reduced life expectancy as compared with the general population. However, there is a lack of
knowledge across Europe concerning interventions that aim at reducing somatic morbidity and
excess mortality by promoting behaviour-based and/or environment-based interventions.
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Methods and design: HELPS is an interdisciplinary European network that aims at (i) gathering
relevant knowledge on physical illness in people with mental illness, (ii) identifying health promotion
initiatives in European countries that meet country-specific needs, and (iii) at identifying best
practice across Europe. Criteria for best practice will include evidence on the efficacy of physical
health interventions and of their effectiveness in routine care, cost implications and feasibility for
adaptation and implementation of interventions across different settings in Europe. HELPS will
develop and implement a "physical health promotion toolkit". The toolkit will provide information
to empower residents and staff to identify the most relevant risk factors in their specific context
and to select the most appropriate action out of a range of defined health promoting interventions.
The key methods are (a) stakeholder analysis, (b) international literature reviews, (c) Delphi rounds
with experts from participating centres, and (d) focus groups with staff and residents of mental
health care facilities.
Meanwhile a multi-disciplinary network consisting of 15 European countries has been established
and took up the work. As one main result of the project they expect that a widespread use of the
HELPS toolkit could have a significant positive effect on the physical health status of residents of
mental health and social care facilities, as well as to hold resonance for community dwelling people
with mental health problems.
Discussion: A general strategy on health promotion for people with mental disorders must take
into account behavioural, environmental and iatrogenic health risks. A European health promotion
toolkit needs to consider heterogeneity of mental disorders, the multitude of physical health
problems, health-relevant behaviour, health-related attitudes, health-relevant living conditions, and
resource levels in mental health and social care facilities.
Background
A large number of studies and reviews from different
countries have revealed that people with mental disorders
have higher rates of physical illness than the general pop-
ulation, and that their risk of premature death due to
physical illness is increased [1-9]. Higher incidence and
prevalence rates for cardiovascular disease (e.g. ischemic
heart disease, cardiac arrhythmias, myocardial infarction)
[1,10], diabetes mellitus (associated with obesity,
impaired glucose tolerance and insulin resistance)
[11,12], several types of cancer and infectious (e.g. HIV/
AIDS) as well as gastrointestinal diseases translate into
reduced life expectancy [1,9,13-18]. Several studies have
examined physical comorbidity in patients with a diagno-
sis of schizophrenia [11,18-23]. Overall mortality in this
target group is double that of the general population [2].
Thus, schizophrenia has been called a "life-shortening dis-
ease" [24]. Causes of unnatural death such as suicide and
accidents account for only part of this increase in mortal-
ity rate; a substantial proportion (59%) is due to natural
causes including physical illness [25,26]. There are sugges-
tions that almost 50% of patients with schizophrenia may
suffer from comorbid physical conditions [19,23]. Diabe-
tes mellitus, cardiovascular disease, hypertension, oste-
oporosis, respiratory disease, and obesity are among the
most common conditions [19-22] in this group. Most
studies have focused on schizophrenia, but excess mortal-
ity due to physical illness is more widespread and has also
been found in other diagnostic groups, e.g. affective and
anxiety disorder [27-37]. Figure 1 shows you several
potential causes of physical comorbidity in people with
severe mental illness.
Behavioural-related causes of physical co-morbidity
The higher prevalence of somatic conditions in people
with mental illness may be related with the mental disor-
der itself and/or unhealthy lifestyle, such as excessive
smoking, poor nutrition, physical inactivity, insufficient
hygiene, dental and sexual health behaviour and hazard-
ous/risk-taking behaviour [14,38-40]. Increased preva-
lence rates for smoking were found among people with
schizophrenia, bipolar and depressive disorder, neurotic
and somatoform disorder [41]. A meta-analysis of 42
studies from 22 countries reported a prevalence of smok-
ing in people with schizophrenia to be about seven times
the general population average for males and three times
higher for females [38]. This leads to a higher rate of nic-
otine-related diseases [1,40,42] and is regarded by several
authors as one of the major causes of high somatic mor-
bidity and also mortality in this patient group [40,43-45].
The odds of hazardous alcohol consumption were three
times higher among patients with depression and dou-
bled for those with schizophrenia [41] although alcohol
use can exacerbate psychotic symptoms and medication
side-effects, e.g. extra pyramidal symptoms [46]. Illicit
drug use was found to be much higher in patients with
schizophrenia, bipolar disorder, depression, neurotic and
somatoform disorder [41,44,46]. Unhealthy food habits
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were found to be increased across diagnostic groups [41],
which included higher proportions of saturated fats,
lower consumption rates of fresh vegetables and fruit and
lower fibre content compared with the general population
[26,40,44,45]. Only a very few studies examined physical
activity and reported lower levels of regular exercise
among people with schizophrenia [40]. Higher rates of
unsafe sex practices with multiple partners and sexual
exploitation among people with mental disorders (partic-
ularly schizophrenia) living in group care homes, hostels
or on the street constitute a risk factor for HIV and AIDS
[1,46]. In general, studies on unhealthy lifestyle habits
and health behaviour of people with mental illness are for
the most part limited to people with schizophrenia and
only little is known about the extent of unhealthy lifestyle
in other diagnostic groups [38,44].
Environmental causes of physical co-morbidity
Health behaviour is influenced by personal features that
interact with social context variables (e.g. social support,
norms and beliefs) and physical factors (e.g. weather, cli-
mate, means of transport, buildings, nutrition and recrea-
tional facilities) [26,47,48]. Furthermore, the living
environment can be a direct determinant through envi-
ronmental constraints and supports, such as physical
activity [49]. Research on physical activity and neighbour-
hood environments indicates that people are more physi-
cally active in neighbourhoods with leisure opportunities
[50,51]. A recent study by Karlin and Zeiss [52] revealed
that sunlight in patient rooms may promote recovery of
patients with severe depression, that exposure to and
views of nature can lead to reduced psychological distress
and fatigue and facilitate recovery, and that big and low
windows may improve sensory abilities and reduce delir-
ium as well as paranoia. Single or non-dormitory-style
resident rooms enhance privacy and autonomy and may
promote participation in treatment activities. Architecture
and building standards have direct effects on residents'
physical health; they shape behavioural opportunities
[26,53], e.g. individual hygiene (bathrooms), physical
activities (gymnasiums, opportunities for sport) and risk
behaviour opportunities (smoking rooms, proximity of
pubs). Organisational aspects, e.g. routine for daily
hygiene and preparation of meals, availability of energy-
dense foodstuffs, regulations and rules e.g. smoking bans
also have effects on residents' physical health.
Professional care-related causes of physical co-morbidity
There are several health system-related factors, including
professional care-related factors. For example, bipolar
patients with a comorbid physical condition often receive
inadequate treatment for their physical condition [33].
Psychiatrists are highly specialised doctors who may, in
common with other specialists, have little or distant expe-
rience of general practice. Opportunities for the early
detection and treatment of physical illness in mentally ill
may therefore be missed [43]. Psychiatric services, with
the encouragement of policy makers, have tended to con-
centrate on the direct consequences of psychotic illness,
for example suicide and dangerousness, rather than the
indirect effects such illness have on physical health [43].
Additionally, there is evidence that patients with schizo-
phrenia have lower rates of utilisation of physical health
care services and the quality of the physical care they
receive is worse as compared with the general population
[54]. Furthermore there is significant empirical evidence
that the physical health of people with mental illness is
often disregarded by mental or general health care institu-
tions [1,55]. At present, neurobiological, psychosocial
and treatment-related factors are assumed to be responsi-
ble for the high prevalence rates of smoking, alcohol and
substance abuse among people with mental illness [56-
62]. In spite of the growing evidence of co-occurrence of
mental and somatic disorder, the nature of relationships
between the two groups of conditions is multiplex due to
the multitude of mechanisms of action and interaction.
The need for prevention programmes
Knowledge on the causes of increased somatic morbidity
and mortality is fragmentary, and standardised screening
instruments for somatic health risks in this population are
not available in routine practice. There is a shortage of sys-
tematic efforts or programmes for the prevention of phys-
ical illness in people with mental disorder [63]. On the
other hand, physical health promotion programmes for
people with mental health needs have been successfully
applied in diverse settings, e.g. local communities [64],
schools [65], prisons [66] and medical care settings [67].
The majority of these intervention programmes have
focused on smoking cessation [68,69], and there are some
programmes for the improvement of dietary behaviour
Potential causes of physical comorbidity in people with sev re mental illnessFigure 1
Potential causes of physical comorbidity in people 
with severe mental illness.
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and physical exercise [63,70]. Many of these programmes
have been initiated by pharmaceutical companies, and
they are related to the issue of antipsychotic-induced
weight gain. Most intervention programmes aim at chang-
ing patient behaviour, whereas they tend to neglect the
role of (unhealthy) environmental living conditions
[38,44]. Most health promoting intervention pro-
grammes were developed and tested in the USA or UK,
and this also limits our knowledge regarding feasibility in
other countries. Thus, there is a striking lack of pro-
grammes targeting unhealthy lifestyle factors related to
poor physical health in people with mental health prob-
lems [39]. Current national surveys and cohorts cannot
provide sufficient information to improve physical health
in people with mental illness, and there appears to be a
lack of resources dedicated to dealing with somatic
comorbidity.
It must not be forgotten that health activities and inter-
ventions aimed at reducing unhealthy lifestyles may actu-
ally have negative effects on the subjective quality of life
of people with mental health problems if these actions are
perceived as restrictive (e.g. smoking bans, restrictions of
sexual contacts) or as paternalistic (e.g. change of nutri-
tion habits, urge for physical activity). Additionally,
smoking can diminish negative symptoms in schizophre-
nia and medication side-effects, e.g. extra pyramidal
symptoms, and it may be perceived as a method to
improve concentration, reduce boredom, negative feel-
ings or anxiety [56-58,60,71-74]. Nicotine consumption,
alcohol, and illicit drug use may also be perceived as
improving social interaction, mood and coping with dis-
tress [57,59,75]. Thus, the unhealthy lifestyle and health
behaviours in people with mental disorder are probably
related to interactions of biological and environmental
factors, as well as to normative beliefs, attitudes, and
behavioural beliefs, which are personal beliefs about the
role of behavior in the process of health and illness (self-
efficacy). The integrative model (figure 2) by Glanz and
colleagues [76] represents the linkage of these factors and
how they impact on behaviour. This complexity has to be
taken into account in planning intervention programmes.
European perspective
The diversity of the European region is evident in psychi-
atric care (as in many other fields). Psychiatric facilities in
Eastern European countries have to provide mental health
care at lower resource levels than in Western Europe; there
is a greater reliance on long-stay institutions yet many are
still to catch up with international developments. On
average, the mental health budget is 5.6% of the total
health budget across Europe, but the proportion varies
from less than 1% in some parts of Eastern Europe to
about 12% in some Western European countries [41]. The
availability of services and coverage by public health sys-
tems varies. Psychiatric hospitals in some Eastern Euro-
pean countries may lack the equipment and services to
recognise and treat physical ill health in people with men-
tal health needs and primary care or internal medicine
input may not be readily available [77]. Eastern European
countries have to cope with low healthcare funding levels,
and out-patient facilities may not be within easy reach.
Community care may not be available [77-80], and the
workload due to mental disorders, including substance
abuse, may be increasing in a context of social instability
[77]. While countries in the eastern half of the European
Union may be catching up with their western European
counterparts mental health appears to still be a recipient
of "second-class treatment".
National and international pharmaceutical companies
that provide modern psychiatric drugs across Europe
influence the field of mental health in rich and poor coun-
tries alike. Thus it can be considered a success that inno-
vative drugs for treating mental disorders are available in
some low resource countries in Central and Eastern
Europe. But providing psychiatric drugs can make the
introduction of psychosocial therapies more difficult in
countries with a low level of healthcare resources. For
example, while the Lithuanian health care system spends
an average of two to three million euros on modern psy-
chiatric drugs, funding for the psychiatric treatment of
children and young people in the secondary and tertiary
sectors is limited to around 1 million euros [81].
Empowerment aspect
The individual should not be considered a passive object
in any prevention strategy but instead take an active part
in the health promotion process [82]. The setting
approach to health promotion should focus on strength-
ening individual abilities and resources of people with
mental illness to empower them to "achieve their fullest
health potential" by "making healthy choices" (World
Health Organization). According to the Ottawa Charta
1996 health promotion programmes should be based on
the concept of empowerment to help individuals increase
the degree of control over their health-related living con-
ditions and quality of life. There is evidence based on
multi-level research designs that empowering initiatives
can improve health outcomes [83]. Service user empower-
ment has developed as a proactive partnership and self-
care strategy to improve health outcomes and quality of
life among the chronically ill [84,85]. Wallerstein defines
empowerment as "a social-action process that promotes
participation of people, or organizations, and communi-
ties towards the goals of increased individual and commu-
nity control, political efficacy, improved quality of life,
and social justice"[86]. Thus empowerment is a complex
strategy in complex environments: effective empower-
ment strategies may depend as much on the agency and
BMC Public Health 2009, 9:315 http://www.biomedcentral.com/1471-2458/9/315
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leadership of the people involved as on the context in
which they are implemented [83].
Need for the project and purpose of HELPS
The obvious neglect of the physical health status of people
with mental illness in general, and of residents in psychi-
atric and social health care facilities in particular, is
incompatible with the protection of human rights and
dignity. Poor physical health in this population must
begin to receive the attention that it deserves, particularly
in view of the substantial numbers of individuals who
spend time in residential facility settings across Europe.
There is a need for a physical health promotion toolkit
that can be implemented not only in the community at
large but also in mental health and social care facilities
across the European Union. The toolkit must comprise an
empowerment strategy which enables professionals and
residents of mental health care facilities to routinely iden-
tify relevant health problems, explore the main causes,
and then choose and implement appropriate health pro-
motion programmes suitable to the range of facilities.
Methods and design
HELPS is a European multi centre project with a project
period from 2008 to 2010, funded by the European
Union, in the framework of the Public Health Pro-
gramme. The 15 countries with centres participating in the
project cover about 80% of the inhabitants of the Euro-
pean Union member states and about 94% of the inhab-
itants of the candidate countries from all geographical
regions of the enlarged Europe. Undertaking this project
within a consortium allows the collection of representa-
tive information on health-related conditions in mental
health care facilities, including the physical health status
of residents and health-related attitudes of residents and
staff members across Europe. The broad geographical cov-
erage in this project is of particular importance because
the great diversity in economic circumstances across the
participating countries is expected to have a significant
impact on health-related conditions in mental health care
facilities. As such HELPS is an interdisciplinary European
network developing health promotion initiatives that
meet country-specific needs. It will identify best practice
(evidence of the efficacy of physical health interventions
and of their effectiveness in routine care, cost implications
issues and feasibility for adaptation and implementation
of interventions) across different settings in Europe.
Project objectives and aims
The overarching objective of HELPS is the development of
a framework of empowerment focusing on the promotion
of healthy living conditions in psychiatric care facilities
and the improvement of the physical health status of res-
idents of psychiatric and social care facilities in the Euro-
pean Region.
For this purpose it is intended to put together a selection
of validated screening instruments and effective and effi-
cient health promotion programmes as an up-to-date and
feasible toolkit to facilitate the treatment of physical ill-
ness in people with mental health needs that is suitable
for application in a wide range of mental health care facil-
ities across Europe. The HELPS toolkit will be embedded
in an empowerment framework for health promotion in
mental health care. Users should be qualified to choose
and implement suitable health promotion programmes at
the individual, organisational and environmental level.
Staff members and residents in these facilities should be
The role of health-related attitudes in the process of health behaviourFigu e 2
The role of health-related attitudes in the process of health behaviour. Glanz et al., 2002.
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enabled to identify routinely the most relevant physical
health problems, to detect adverse and protective health-
related lifestyles and attitudes, to discover relevant facility
characteristics, and HELPS should increase staff members'
and residents' control over their living conditions and
their confidence in the effect of their own actions to
improve health status. To assess the validity and feasibility
of applying the health promotion toolkit, a pilot applica-
tion phase will be carried out in at least one psychiatric or
social care facility in each of the participating countries.
Experiences from this pilot phase will be used to improve
parts of the toolkit which are not suitable for routine
application.
It is planned to translate the HELPS toolkit into the fol-
lowing European languages: English, Bulgarian, Danish,
Czech, Estonian, French, German, Italian, Lithuanian,
Polish, Romanian, Slovenian, Spanish, and Turkish. This
would cover the languages of about 80% of the citizens of
EU member states and about 96% of the citizens of candi-
date countries. A standardised translation procedure
should facilitate adaptation to further languages. Thus we
expect to enable access not only to the participating cen-
tres but to all individuals or facilities who are interested in
the health promotion of people with mental illness. The
HELPS toolkit shall be accessible via the internet and as a
CD ROM. We hope that media campaigns will be a help-
ful way for dissemination, application, and implementa-
tion of the toolkit. It will be complemented by a training
manual using multimedia presentations to introduce key
targets of the HELPS toolkit and describe its component
parts. Furthermore it is projected to offer workshops on
the use of the paper-pencil and computer versions of
assessment instruments. This practical training should
enable participants to pass on the skills required to handle
the toolkit in peer groups and, in this way, they could
become multipliers in dissemination of the toolkit.
Methods
The key methods used in this project are: (a) international
literature reviews, (b) stakeholder analysis, (c) Delphi
exercises, and (d) focus groups:
(a) International literature reviews (ILR) will be used to
collect fragmented knowledge on the prevalence of phys-
ical illness in people with mental illness and information
on standardised methods for the assessment of physical
health status, health-relevant lifestyle, and health related
attitudes among people with mental disorder to get a
comprehensive picture of the international knowledge
and the international state of the art of measurement in
this field. ILR will also be used to identify effective and
cost-effective health promotion programmes appropriate
for routine use in mental health and social care facilities.
In addition to searching electronic databases, HELPS part-
ners will also search the "grey literature" to identify other
useful sources of information on these topics.
(b) Heterogeneity in different respects (e.g. policy, eco-
nomic situation, cultural norms) between and within the
participating countries is evident. Therefore, extensive
consultation with relevant stakeholders will be under-
taken. Stakeholder analysis [87] will be conducted in each
country to identify relevant stakeholders for the HELPS
project and to determine the best ways they can be
involved in the project. The stakeholder analysis has the
intention of developing collaborative links between stake-
holders and project partners. Stakeholders will act as advi-
sors, name the relevant multipliers for the dissemination
of project results and the toolkit, and they will ensure the
development successful project outcomes.
(c) Participants of Delphi exercises will be identified
through stakeholder analysis, and these will be selected
on the basis of their expertise, rated through publications
or positions held. Delphi exercises will be conducted to
identify available data (1) on the prevalence and causes of
physical health problems in residents of mental health
care facilities, (2) on the adequacy of assessment meth-
ods, (3) on the availability of health promotion pro-
grammes, and on the extent of their implementation in
mental health care facilities.
(d) Focus groups [88-90] will be conducted in acute and
long-stay facilities in each participating country in order
to capture the social, economic, and cultural diversity of
the enlarging European Union. The aim is to gather infor-
mation on residents' and staff members' subjective per-
ception of physical health problems, their thoughts and
beliefs on the causes of the physical health risks, and their
acceptance and ideas regarding physical illness prevention
strategies and interventions programmes for physical
health promotion. Since the focus group method is an
explorative qualitative research technique, no formal
power calculation can be made to determine sample size.
Instead, the variety and the number of focus groups to
conduct will be determined on the basis of the theoretical
sampling model [91,92], and by the level of segmentation
of the study population. Once the criteria for segmenta-
tion have been identified (in our case: "professionals" and
"patients/residents"), it is usual practice to conduct at
least two focus groups within each sub-group of the study
population [93-97]. Initially, all centres will start with
conducting one focus group with residents and one focus
group with staff members. After the data of the first focus
groups are analyzed researchers in the centres will decide
whether a stage of theoretical saturation is reached or
whether additional groups are necessary.
Inclusion criteria for residents are: (a)participants have to
be 18 years old or older, and (b) they need to have a psy-
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chiatric diagnosis. Resident exclusion criteria are: (a) sub-
stance abuse as primary diagnosis; (b) the presence of a
moderate or severe intellectual disability or organic men-
tal disorder (such as Alzheimer's Disease); (c) a current
treatment by forensic psychiatric services; (d) the insuffi-
cient command of the national language in order to take
part in the focus group; and (e) a lack of capacity to give
valid consent.
The HELPS Coordinating Centre (Ulm University)
requested and received ethics approval for the project
from the "Ethikkommission der Universität Ulm", Ger-
many. In addition, the following centres requested and
received ethics approval from their appropriate facility
review board and/or ethics committee: Austria: Ethik-
Kommission der Medizinischen Universität Wien und des
Allgemeinen Krankenhauses der Stadt Wien; Czech
Republic: Eticka komise Psychiatrickeho centra Praha;
Denmark: Den Videnskabsetiske Komite for Region Nor-
djylland; Estonia: Ethics Review Committee (ERC) on
Human Research of the University of Tartu; Italy: Comi-
tato Etico Provinciale per la sperimentazione clinica di
Verona; Lithuania: Vilniaus Regioninis Biomedicininiu
Tyrimu Etikos Komitetas; Poland: Instytut Psychiatrii i
Neurologii komisja bioetyczna; Slovenia: Komisija
Republike Slovenije za Medicinsko Etiko; Spain: Comi-
sion de Etica en la Experimentacion Animal y Humana
(CEEAH); Turkey: Ethical Committee for Clinical and
Labaratuar Research of Dokuz Eylül University School of
Medicine; United Kingdom: East London and the City
Local Research Ethics committee 2.
Discussion
Improving the physical health of people with mental ill-
ness is a complex issue. Knowledge and awareness of risk
factors relevant to physical health is required in order to
develop behavioural or environmental prevention pro-
grammes. A European health promotion programme
must take into consideration that there is substantial var-
iation across countries regarding the use of residential care
facilities, the extent to which they consider physical health
problems, health-relevant behaviour, health-related atti-
tudes of service users/residents, health-relevant living con-
ditions and resource levels in residential mental health
care facilities.
A widespread use of the "HELPS health promotion
toolkit" is expected to have a significant positive effect on
the physical health status of residents of mental health
and social care facilities, as well as to hold resonance for
community dwelling people with mental health prob-
lems. In addition, dissemination of the toolkit will
become one element of a European strategy to improve
living conditions in these facilities. Furthermore, it is
expected that the HELPS toolkit will be perceived by staff
members and residents of mental health care facilities as
an opportunity to increase control and enhance their
quality of life.
However, it should be recognised that a substantial pro-
portion of the excess physical morbidity may be not
address by tackling these factors. Some of the risks of
physical ill health in people with mental illness are likely
to be inherent. Changes in the immune system and hor-
monal unbalance are potential risk factors. According to
the Mental Health Declaration and the Mental Health
Action Plan for Europe http://www.euro.who.int/mental
health/publications/20061124_1, agreed upon in Hel-
sinki in conditions among people with mental illness in
Europe is now a priority of European health policy. The
promotion of healthy living conditions and the preven-
tion of physical comorbidity are preconditions for main-
taining the dignity and the human rights of residents of
mental health care facilities. In summary, we expect that
these project outcomes will also make an important con-
tribution to maintaining and enhancing the dignity,
human rights and general health of residents of mental
health care facilities in Europe.
Conclusion
Due to the great variance in health-relevant characteristics
of mental health care facilities in participating countries,
the provision of a uniform health promotion programme
for all facilities would not be appropriate. On the other
hand, the mere provision of a number of health promo-
tion programmes to choose from would be insufficient
because the majority of staff members and residents of
mental health care facilities will have no experience in ini-
tiating health promoting interventions. Therefore, the
project has to use a strategy of supported decision making,
allowing staff members and residents to select the most
appropriate health promoting actions. A strategy is
needed which enables people in mental health care facili-
ties to routinely identify the most relevant health prob-
lems, explore the main causes for these health problems,
and then choose appropriate intervention programmes
and systematically evaluate their effects.
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